Inventor · disambiguated record
Jianfeng Pan
Also filed as: PAN JIANFENG
8 granted patents·6 pending applications·17 citations·filing 2011–2024
80Inventor score
Files withNOVARTIS AG4CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2SHANGHAI RINGENE BIOPHARMA CO LTD2WU TOM YAO HSIANG2GLAXOSMITHKLINE BIOLOGICALS SA1
Top patents by PatentIndex Score
14 records- 0184US9315530B2Adsorption of immunopotentiators to insoluble metal saltsSINGH MANMOHAN·Filed 2011·Granted Apr 19, 2016·7 cites·18 claims
- 0280US9365506B2Compounds and compositions as TLR2 agonistsWU TOM YAO-HSIANG·Filed 2014·Granted Jun 14, 2016·5 cites·18 claims
- 0377US11993596B2Fused tri-cyclic compound as PDE3/PDE4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted May 28, 2024·1 cites·21 claims
- 0476US8808703B2Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etcWU TOM YAO-HSIANG·Filed 2011·Granted Aug 19, 2014·4 cites·18 claims
- 0573US2024294526A1Fused tri-cyclic compound as a pde3/pde4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2024·Application pending·0 cites
- 0665US2023190751A16-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS InhibitorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0760US2025206763A1Enpp1 inhibitorSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2023·Application pending·0 cites
- 0853US10098949B2Adsorption of immunopotentiators to insoluble metal saltsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Oct 16, 2018·0 cites·14 claims
- 0952US11458138B26-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitorsNOVARTIS AG·Filed 2018·Granted Oct 4, 2022·0 cites·14 claims
- 1052US2023348852A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1151US12281118B2Nitrogen-containing fused heterocyclic SHP2 inhibitor compound, preparation method, and useSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2019·Granted Apr 22, 2025·0 cites·6 claims
- 1245US2020131474A1Methods and compositions for ocular cell therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1341US12459939B2Acylaminopyrrolo-pyridone compound, preparation method therefor and use thereofSHANGHAI RINGENE BIOPHARMA CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·14 claims
- 1435US2018104220A1Imidazole compoundMEDSHINE DISCOVERY INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jianfeng Pan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →